[Methods in Enzymology] Gene Expression Technology Volume 185 || [1] Systems for heterologous gene expression
- 作者Goeddel, David V.
- 文件大小263.46KB
- 发表时间1990
- DOI10.1016/0076-6879(90)85003-7
- 页码3-7
8-Carboxamidocyclazocine analogues: redefining the structure–activity relationships of 2,6-methano-3-benzazocinesMark P. Wentland; Rongliang Lou; Yingchun Ye; Dana J. Cohen; Gregory P. Richardson; Jean M. Bidlack · 2001
Redefining the structure–activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analoguesMark P. Wentland; Xufeng Sun; Yingchun Ye; Rongliang Lou; Jean M. Bidlack · 2003
ChemInform Abstract: 8-Carboxamidocyclazocine Analogues: Redefining the Structure—Activity Relationships of 2,6-Methano-3-benzazocines.Mark P. Wentland; Rongliang Lou; Yingchun Ye; Dana J. Cohen; Gregory P. Richardson; Jean M. Bidlack · 2001
Redefining the structure–activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocineMark P. Wentland; Xufeng Sun; Yigong Bu; Rongliang Lou; Dana J. Cohen; Jean M. Bidlack · 2005
Redefining the structure–activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocineMark P. Wentland; Xufeng Sun; Dana J. Cohen; Jean M. Bidlack · 2008
Redefining the structure–activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4′-phenyl)-phenethyl) analogues of 8-CACMelissa A. VanAlstine; Mark P. Wentland; Dana J. Cohen; Jean M. Bidlack · 2007
Redefining the structure–activity relationships of 2,6-methano-3-benzazocines. Part 7: Syntheses and opioid receptor properties of cyclic variants of cyclazocineMark P. Wentland; Qun Lu; Rakesh Ganorkar; Shao-Zhong Zhang; Sunjin Jo; Dana J. Cohen; Jean M. Bidlack · 2009
Redefining the Structure−Activity Relationships of 2,6-Methano-3-benzazocines. 4. Opioid Receptor Binding Properties of 8-[ <i>N</i> -(4‘-phenyl)-phenethyl)carboxamido] Analogues of Cyclazocine and EthylketocycalzocineWentland, Mark P.; VanAlstine, Melissa; Kucejko, Robert; Lou, Rongliang; Cohen, Dana J.; Parkhill, Amy L.; Bidlack, Jean M. · Journal of Medicinal Chemistry · 2006
Cyclophilin inhibitors as antiviral agentsPeel, Michael; Scribner, Andrew · Bioorganic & Medicinal Chemistry Letters · 2013
HIV/AIDS eradicationMarsden, Matthew D.; Zack, Jerome A. · Bioorganic & Medicinal Chemistry Letters · 2013
Selective orexin receptor antagonistsLebold, Terry P.; Bonaventure, Pascal; Shireman, Brock T. · Bioorganic & Medicinal Chemistry Letters · 2013
Graphical contents listBioorganic & Medicinal Chemistry Letters · 2013
REDOR NMR for drug discoveryCegelski, Lynette · Bioorganic & Medicinal Chemistry Letters · 2013
Editorial boardBioorganic & Medicinal Chemistry Letters · 2014
Graphical contents listBioorganic & Medicinal Chemistry Letters · 2014
Editorial boardBioorganic & Medicinal Chemistry Letters · 2013